We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

1 hedge funds and large institutions have $52 invested in ChemoCentryx, Inc. in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 212 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 217 → 1 (-216)

100% less funds holding in top 10

Funds holding in top 10: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $3.2B → $52 (-$3.2B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 212

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-216
Holders Change %
-99.54%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
212
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$311M
2
Goldman Sachs
Goldman Sachs
New York
-$290M
3
BlackRock
BlackRock
New York
-$250M
4
UOC
UBS O'Connor
Illinois
-$141M
5
State Street
State Street
Massachusetts
-$140M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
26
Balyasny Asset Management
Illinois
– -$36.8M -713,026 Closed
Morgan Stanley
27
Morgan Stanley
New York
– -$35.3M -684,161 Closed
GKIM
28
GW&K Investment Management
Massachusetts
– -$35.3M -683,702 Closed
Principal Financial Group
29
Principal Financial Group
Iowa
– -$34.2M -661,883 Closed
Northern Trust
30
Northern Trust
Illinois
– -$34M -658,607 Closed
AA
31
AQR Arbitrage
Connecticut
– -$31.3M -605,045 Closed
AllianceBernstein
32
AllianceBernstein
Tennessee
– -$30.4M -588,213 Closed
Assenagon Asset Management
33
Assenagon Asset Management
Luxembourg
– -$28M -542,817 Closed
Allianz Asset Management
34
Allianz Asset Management
Germany
– -$28M -541,480 Closed
GF
35
Gabelli Funds
New York
– -$27.5M -532,080 Closed
PMAM
36
Picton Mahoney Asset Management
Ontario, Canada
– -$26.3M -509,142 Closed
Charles Schwab
37
Charles Schwab
California
– -$23.6M -457,772 Closed
AAM
38
Alpine Associates Management
Florida
– -$23.5M -455,000 Closed
SSA
39
Schonfeld Strategic Advisors
New York
– -$19.5M -376,583 Closed
E
40
Ergoteles
New York
– -$19.3M -373,020 Closed
KL
41
KIM LLC
Kansas
– -$19.1M -369,544 Closed
Bank of America
42
Bank of America
North Carolina
– -$18.6M -360,036 Closed
Tudor Investment Corp
43
Tudor Investment Corp
Connecticut
– -$18.4M -357,000 Closed
CCM
44
Chicago Capital Management
Illinois
– -$16.6M -321,580 Closed
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
– -$16.6M -320,461 Closed
GCIA
46
Gabelli & Co Investment Advisers
New York
– -$15.9M -307,358 Closed
GLAM
47
Gardner Lewis Asset Management
Pennsylvania
– -$15.4M -298,160 Closed
Deutsche Bank
48
Deutsche Bank
Germany
– -$14.4M -278,005 Closed
HSBC Holdings
49
HSBC Holdings
United Kingdom
– -$14M -270,839 Closed
Bank of New York Mellon
50
Bank of New York Mellon
New York
– -$13.8M -267,627 Closed
1
2
3 4 5

CCXI Hedge Fund Activity: Q4 2022 in Review

1 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2022, worth a combined $52 — down 100% from $3.2B a quarter earlier.

Sellers outnumbered buyers: 212 funds closed out of CCXI and 0 opened new positions — a net loss of 212 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $311M sold.

  • 1 institutional investor held ChemoCentryx, Inc. (CCXI) as of Q4 2022, down from 217 in Q3 2022.
  • Funds reported $52 of ChemoCentryx, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new ChemoCentryx, Inc. positions in Q4 2022 and 212 closed out, a net change of -212 holders.
  • The largest ChemoCentryx, Inc. seller in Q4 2022 was Vanguard Group, an estimated $311M sold.

Based on aggregated 13F filings for Q4 2022.